Hypopharyngeal Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Clinical Trials
• Forums

Sequential Therapy With Induction TPN Followed by Nivolumab With Radiation in Locoregionally Advanced Laryngeal and Hypopharyngeal Cancer
Condition:   Head and Neck Cancer Interventions:   Drug: Nivolumab;   Drug: Cisplatin;   Drug: Docetaxel;   Radiation: Radioimmunotherapy Sponsors:   Dana-Farber Cancer Institute;   Bristol-Myers Squibb Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2019 Category: Research Source Type: clinical trials

Induction TPN Followed by Nivolumab With Radiation in Locoregionally Advanced Laryngeal and Hypopharyngeal Cancer
Condition:   Head and Neck Cancer Interventions:   Drug: Nivolumab;   Drug: Cisplatin;   Drug: Docetaxel;   Radiation: Radioimmunotherapy Sponsors:   Dana-Farber Cancer Institute;   Bristol-Myers Squibb Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2019 Category: Research Source Type: clinical trials